Vertex Pharmaceuticals Incorporated VRTX

Set alert

Price alert · VRTX

All alert types
553.15 USD 0.00 0.00%

At close

568.23 +15.08 +2.73%

Pre-market · Nov 3, 9:16 AM ET

Bid
553.96 × 1
Ask
556.05 × 2
544.09 Day range 568.67
403.16 52-week range 568.67
YTD
+22.01%
1 year
+29.85%
Open
560.88
Prev close
553.15
Mkt cap
140.11B
Vol
3.21M
Avg vol
1.22M
EPS
17.17
P/E
32.22
Div yield
0.00%
More statistics
Low
544.09
High
568.67
Forward P/E
27.09
Beta
0.28
Short ratio
3.66
Inst. own
98.10%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2027
50-d avg
523.21
200-d avg
479.21
1y target
571.46

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Events in this range
  • Nov 2, 2026Earnings: 4.76; estimate 4.82; surprise -1.24%
Signals (19)
NameTimeAgo
SMA: BearishNov 2, 4:00 PM17 hours ago
SMA: BullishNov 2, 3:55 PM17 hours ago
SMA: BearishNov 2, 2:25 PM18 hours ago
SMA: BullishNov 2, 1:55 PM19 hours ago
SMA: BearishNov 2, 1:25 PM19 hours ago
SMA: BearishNov 2, 12:55 PM20 hours ago
SMA: BullishNov 2, 9:55 AM23 hours ago
RSI: OverboughtNov 2, 9:55 AM23 hours ago
SMA: BearishOct 30, 3:25 PM3 days ago
MACD: Sell SignalOct 30, 2:55 PM3 days ago
RSI: OverboughtOct 30, 1:55 PM3 days ago
MACD: Buy SignalOct 30, 9:55 AM4 days ago
RSI: OverboughtOct 30, 9:55 AM4 days ago
SMA: BullishOct 29, 3:25 PM4 days ago
SMA: BearishOct 29, 1:25 PM4 days ago
RSI: OverboughtOct 29, 9:55 AM5 days ago
SMA: BullishOct 28, 3:55 PM5 days ago
SMA: BearishOct 28, 2:55 PM5 days ago
RSI: OverboughtOct 28, 1:25 PM5 days ago

Analyst view

Consensus: buy

Buy
Price target (mean) 571.46 +3.3% upside
Target (low)
350.00
Target (mean)
571.46
Target (high)
667.00
Ratings (0m) 32 26 buy · 4 hold · 2 sell
  • Strong buy6
  • Buy20
  • Hold4
  • Sell1
  • Strong sell1

Recommendation trend

  • This month 32
  • 1 month ago 32
  • 2 months ago 29

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VRTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter4.783.68 – 5.254.80-0.3%3.43B+11.7%13
Next quarter4.644.04 – 5.225.03-7.7%3.53B+10.7%16
Current year18.7717.61 – 19.5418.40+2.0%13.28B+10.7%17
Next year20.4217.86 – 23.0618.77+8.8%14.60B+9.9%19

Upgrades and downgrades

The latest rating changes

VRTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Sep 28, 2026UBSMaintainedBuyBuy
Aug 5, 2026Truist SecuritiesMaintainedBuyBuy
Aug 5, 2026BarclaysMaintainedOverweightOverweight
Aug 4, 2026TD CowenMaintainedBuyBuy
Aug 4, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Aug 4, 2026Canaccord GenuityMaintainedHoldHold
Jul 13, 2026UBSMaintainedBuyBuy
Jul 13, 2026Truist SecuritiesMaintainedBuyBuy
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jul 7, 2026BairdMaintainedUnderperformUnderperform
May 6, 2026BarclaysMaintainedOverweightOverweight
May 5, 2026Canaccord GenuityMaintainedHoldHold
May 5, 2026Morgan StanleyMaintainedOverweightOverweight
May 5, 2026BernsteinMaintainedOutperformOutperform
May 5, 2026RBC CapitalMaintainedOutperformOutperform
Apr 30, 2026Canaccord GenuityMaintainedHoldHold
Apr 10, 2026Morgan StanleyMaintainedOverweightOverweight
Mar 18, 2026Maxim GroupUpgradeHoldBuy
Mar 11, 2026Truist SecuritiesMaintainedBuyBuy
Mar 10, 2026Morgan StanleyMaintainedOverweightOverweight
Mar 10, 2026B of A SecuritiesMaintainedBuyBuy
Mar 10, 2026CitigroupMaintainedBuyBuy
Mar 10, 2026OppenheimerMaintainedOutperformOutperform
Mar 10, 2026JefferiesInitiated—Buy
Mar 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 17, 2026Canaccord GenuityMaintainedHoldHold
Feb 17, 2026BarclaysMaintainedOverweightOverweight
Feb 17, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 13, 2026ScotiabankMaintainedSector PerformSector Perform